ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 133 filers reported holding ATEA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,668 | -38.7% | 504 | -25.2% | 0.00% | – |
| Q1 2024 | $2,723 | -81.8% | 674 | -86.3% | 0.00% | – |
| Q4 2023 | $14,975 | +6.9% | 4,910 | +5.2% | 0.00% | – |
| Q3 2023 | $14,007 | -16.9% | 4,669 | +3.6% | 0.00% | – |
| Q2 2023 | $16,859 | +11.6% | 4,508 | 0.0% | 0.00% | – |
| Q1 2023 | $15,101 | -81.5% | 4,508 | -73.5% | 0.00% | – |
| Q4 2022 | $81,808 | +227.2% | 17,008 | +277.3% | 0.00% | – |
| Q3 2022 | $25,000 | -3.8% | 4,508 | +25.1% | 0.00% | – |
| Q2 2022 | $26,000 | -61.2% | 3,603 | -62.2% | 0.00% | – |
| Q1 2022 | $67,000 | -95.5% | 9,542 | -94.2% | 0.00% | -100.0% |
| Q4 2021 | $1,477,000 | -70.1% | 164,962 | +15.8% | 0.00% | -75.0% |
| Q3 2021 | $4,934,000 | +11934.1% | 142,514 | +8302.9% | 0.01% | – |
| Q2 2021 | $41,000 | – | 1,696 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 5,462,079 | $16,659,341 | 12.62% |
| TANG CAPITAL MANAGEMENT LLC | 4,076,741 | $12,434,060 | 1.15% |
| Stonepine Capital Management, LLC | 839,514 | $2,560,518 | 1.11% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $7,581,196 | 0.73% |
| CM Management, LLC | 270,000 | $823,500 | 0.66% |
| EcoR1 Capital, LLC | 6,995,861 | $21,337,376 | 0.55% |
| Acuitas Investments, LLC | 171,098 | $615,373 | 0.32% |
| Newtyn Management, LLC | 508,474 | $1,550,846 | 0.30% |
| Diametric Capital, LP | 161,524 | $492,648 | 0.30% |
| Auour Investments LLC | 177,000 | $670,830 | 0.26% |